Company Filing History:
Years Active: 2007-2013
Title: Catherine Smith: Innovator in Polypeptide Research
Introduction
Catherine Smith is a prominent inventor based in Union, NJ (US). She has made significant contributions to the field of polypeptide research, holding a total of 3 patents. Her work focuses on the development of innovative methods and compounds that have the potential to advance drug design.
Latest Patents
Among her latest patents, Catherine has developed crystals of the MEK1 polypeptide, which are particularly useful for structure-based drug design. This invention provides valuable insights into the molecular structure of MEK1, facilitating the design of new therapeutic agents. Additionally, she has patented methods for crystallizing ERK2 polypeptides, which also contribute to structure-assisted drug design. These advancements highlight her expertise in the field and her commitment to improving drug development processes.
Career Highlights
Catherine has worked with notable companies such as Schering Corporation and Merck Sharp & Dohme Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the pharmaceutical industry, further enhancing her skills and knowledge in polypeptide research.
Collaborations
Throughout her career, Catherine has collaborated with esteemed colleagues, including Paul Reichert and Jessie M English. These partnerships have played a crucial role in her research and have contributed to her success as an inventor.
Conclusion
Catherine Smith is a dedicated inventor whose work in polypeptide research has led to significant advancements in drug design. Her innovative patents and collaborations with industry leaders underscore her impact on the field.